ICNRID · Registering as Listener

International Conference on Next-Generation Research in Infectious Diseases

9th Jun – 10th Jun 2027 Doha, Qatar Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICNRID
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Next-Generation Research in Infectious Diseases conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 6 - Clean Water and Sanitation SDG 9 - Industry, Innovation and Infrastructure

This track focuses on the latest advancements in genomic research related to HIV/AIDS, emphasizing the role of next-generation sequencing technologies. Participants will explore how genomic data can inform personalized treatment strategies and enhance our understanding of viral evolution.

This session will address the challenges posed by emerging pathogens in individuals with HIV/AIDS, highlighting the complexities of co-infections. Discussions will include epidemiological trends and the implications for public health interventions.

This track will showcase innovative diagnostic techniques for HIV/AIDS, including rapid tests and molecular assays. The focus will be on improving accuracy, accessibility, and timeliness of HIV diagnosis in various populations.

This session will delve into the latest strategies in the development of effective vaccines against HIV/AIDS. Researchers will present findings on novel vaccine candidates and discuss the challenges of inducing robust immune responses.

This track will examine the latest advancements in antiviral therapies for HIV/AIDS, including novel drug classes and treatment regimens. Participants will discuss the implications of these therapies on patient outcomes and resistance patterns.

This session will focus on the molecular biology of HIV, exploring the mechanisms of viral replication and pathogenesis. Researchers will discuss potential therapeutic targets that could lead to innovative treatment options.

This track will investigate the immune responses elicited by HIV infection and their implications for disease progression and treatment. Presentations will cover both innate and adaptive immunity, as well as strategies to enhance immune function.

This session will provide insights into the design and implementation of clinical trials focused on HIV/AIDS interventions. Participants will discuss best practices for trial methodology, patient recruitment, and data analysis.

This track will explore the global health implications of HIV/AIDS, focusing on disparities in access to care and treatment across different regions. Discussions will include strategies for improving health equity and outcomes in affected populations.

This session will present the latest epidemiological data on HIV/AIDS, highlighting trends in infection rates, demographics, and risk factors. Participants will discuss the implications of these trends for public health policy and intervention strategies.

This track will focus on translational research efforts aimed at bridging the gap between laboratory findings and clinical applications in HIV/AIDS. Researchers will present case studies that illustrate successful translation of research into practice.

COPYRIGHT © 2026 International Conference on Next-Generation Research in Infectious Diseases. ALL RIGHTS RESERVED